High Stability Probiotics Bacillus Coagulans Capsule

• Customization: Available
• CAS No.: N
• Formula: N
• Model NO.: BC01
• EINECS: N
• Resource: Natural
• Smell: Addable
• Appearance: Hard Shell Capsule
• Net Content: 1,000grains
• Cfu: 50b
• Identification: 16s Rrna
• Transport Package: Insulated Package
• Specification: TBC
• Trademark: BIODEP
• Origin: China
• HS Code: 21069090
• Production Capacity: 50, 000bags/M

Product Description

Instruction
      Bacillus coagulans BC01, isolated from thick broad-bean sauce. B. coagulans BC01 is widely used in China, where it is considered a treatment for diarrhea, constipation, and allergies and an immunity booster. 
      ChaChanges in the body weights of mice. NC, normal group; M, constipation model group; DC, bisacodyl control group; BC01-H, BC01 high-dose group; BC01-L, BC01 low-dose group (n = 8).nges in the body weights of mice. NC, normal group; M, constipation model group; DC, bisacodyl control group; BC01-H, 
B. Changes of fecal moisture content in mice. NC, normal group; M, constipation model group; DC, bisacodyl control group; BC01-H, BC01 high-dose group; BC01-L, BC01 low-dose group (N= 8).
   Small intestinal propulsion rate in mice. (A) Small intestine anatomy. Small bowel advancement rate. The different letters Small intestinal propulsion rate in mice. Small intestine anatomy. Small bowel advancement rate. The different letters among the experimental groups indicated statistical differences (p < 0.05). NC, normal group; M, constipation model group; DC, bisacodyl control group; BC01-H, BC01 high-dose group; BC01-L, BC01 low-dose group (n = 8).
Histology of the small intestine tissue sections stained with H&E stain. NC, normal group; M, constipation model group; DC, bisacodyl control group; BC01-H, BC01 high-dose group; BC01-L, BC01 low-dose group.
Effects of BC01 on the intestinal microbiota composition in the constipated mice. A Venn plot of shared and unique ASVs in mouse gut microbiota. B Shannon index of the ASV level. C ASV level principal co-ordinates analysis using Bray-Curtis metrics. NC, normal group; M, constipation model group; DC, bisacodyl control group; BC01-H, BC01 high-dose group; BC01-L, BC01 low-dose group (N= 4).
Regulation

Legislation can be varied by country when it comes to specific dosage and potential health claims of each strain.

Our regulatory team can help and advise you as to the appropriate individual markets permit. We are committed to deliver expert advice and practical solutions in order to optimize your company's success.

Storage
Keep 5-15 DC and out of sunlight, keep away from children.

More;

LIST OF STRAINS
Probiotics	Strain Number	Type(CFU/g)
Lactiplantibacillus plantarum	Lp3a	5-500B
Lacticaseibacillus rhamnosus	LR05	5-400B
Lacticaseibacillus casei	LC11	5-400B
Lacticaseibacillus paracasei	LPC45	5-400B
Lactobacillus fermentum	LF021	5-300B
Lactobacillus salivarius	LS01	5-100B
Lactobacillus reuteri	LR06	5-200B
Lactobacillus acidophi/us	LA16	5-200B
Lactobacillus  helveticus	LH030/LZ-R-5	5-200B
Lactobacillus crispatus	LCP051	5-100B
Lactobacillus gasseri	LG021/LG019	5-200B
Lactobacillus johnsonii	LJ10	5-100B
Lactobacillus delbrueckii subsp. bulgaricus	LB45	5-20B
Bifidobacterium animalis subsp. lactis	Bla019	5-400B
Bifidobacterium animalis subsp. animalis	BA023	5-500B
Bifidobacterium breve	BB033	5-200B
Bifidobacterium longum subsp. longum	BL5b	5-100B
Bidobacterium longum subsp. infantis	BI08	5-50B
Bifidobacterium bifidum	BMC31	5-200B
Bifidobacterium adolesentis	BAA021	5-100B
Streptococcus salivarius subsp. thermophilus	ST076	5-300B
Pediococcus pentosaceus	PP016	5-300B
Pediococcus acidolactici	PAL31	5-400B
Leuconostoc mesenteroides subsp. mesenteroides	LCM020	5-200B
Weizmannia  coagulans	BC01	5-100B
Akkermansia  muciniphila	AMP018	5-200B